Adaptive Biotechnologies stock price
어댑티브 바이오테크놀로지스NASDAQ:ADPT · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Adaptive Biotechnologies last closed at $28.35 (+3.58%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -70.0×. Its overall grade ranks 158 of 739 stocks in Healthcare.
About this company
Adaptive Biotechnologies last closed at $28.35 (+3.58%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 158/739
Valuation grade A
Related stocks
- IlluminaSupplier
NGS 기반 면역레퍼토리 분석에 쓰이는 주요 시퀀싱 장비·플랫폼 공급사
- Thermo Fisher ScientificSupplier
분석·실험실 장비와 시약을 공급하는 대표적 생명과학 인프라 업체
- PacBioSupplier
장기리드 시퀀싱 등 고정밀 유전체 분석에 활용되는 플랫폼 공급사
ETFs holding this stock
Franklin Genomic Advancements ETF · ROBO Global Healthcare Technology & Innovation ETF
Details →About Adaptive Biotechnologies
- What technical signals does Adaptive Biotechnologies (ADPT) have?
- Adaptive Biotechnologies current technical signals: no active technical signal.
- Is Adaptive Biotechnologies a cup-and-handle pattern?
- No. Adaptive Biotechnologies has no valid Cup signal right now.
- What published figures are available for Adaptive Biotechnologies?
- Market cap: $4.33B. Trailing 12 months PER: -70.0×. Latest quarter PBR: 29.67×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Adaptive Biotechnologies, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).